Skip to main content

Table 1 Characteristics of the study population in Erfurt, Germany, winter 2000/2001

From: Ultrafine particles and platelet activation in patients with coronary heart disease – results from a prospective panel study

  

Mean (SD)

Age [years]

 

66 (6.0)

BMI* [kg/m 2 ]

 

28 (3.4)

  

No. (%)

History of

  
 

Coronary heart disease

57 (100)

 

Angina pectoris

40 (68)

 

Myocardial infarction

43 (75)

 

Bypass surgery/balloon dilatation

49 (86)

 

Stroke

3 (5)

 

Diabetes mellitus

13 (23)

 

Hypertension

40 (70)

 

Chronic bronchitis

2 (4)

 

COPD

5 (9)

 

Hay fever

2 (4)

 

Chronic kidney disease

6 (11)

Smoking

  
 

Never smoker

15 (26)

 

Ex-smoker

42 (74)

Medication use

Anti-hyperlipidemic medication

29 (51)

 

Platelet aggregation inhibitors

 
 

   Acetylsalicylic acid

52 (91)

 

   Thienopyridines

3 (5)

  1. * BMI, Body mass index
  2. † COPD, Chronic obstructive pulmonary disease
  3. ‡ SD, standard deviation